Allan Jonathan 4

What Happened

• Allan Jonathan, General Counsel & Corporate Secretary of Stoke Therapeutics (STOK), sold 1,457 shares in an open-market/private sale on June 16, 2026. The shares were disposed at $29.95 per share for a total of approximately $43,637. This was a sale (not a purchase).

Key Details

• Transaction date: 2026-06-16
• Price: $29.95 per share
• Shares sold: 1,457
• Total proceeds: ≈ $43,637
• Shares owned after transaction: Not specified in the provided filing excerpt
• Filing date: 2026-06-18 (filed two days after the transaction; appears timely)
• Footnote: Transaction executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025

Context

• The sale was done under a pre-established 10b5-1 trading plan, which allows insiders to sell shares according to a preset schedule and can limit the informational value of the sale as a signal of the insider’s short-term view. Sales are often routine; purchases are generally considered more informative about insider confidence.